Academia and Clinic
15 July 1991

Can Physician Education Lower the Cost of Prescription Drugs?: A Prospective, Controlled Trial

Publication: Annals of Internal Medicine
Volume 115, Number 2

Abstract

▪ Objective: To determine whether an educational program featuring a drug cost manual can assist physicians in reducing their patients' out-of-pocket prescription drug expenses.
▪ Design: Prospective controlled trial.
▪ Setting: A general internal medicine-teaching clinic in a university hospital.
▪ Participants: Fifty-one medical interns.
▪ Intervention: Thirty-one interns received a manual of comparative drug prices annotated with prescribing advice, two feedback reports, and weekly cost-oriented prescribing reminders. A control group concurrently participated in a manual-based educational program on cholesterol management.
▪ Measurements: Copies of 3012 prescriptions written over 8 months were analyzed.
▪ Main Results: Intervention group physicians prescribed less expensive drugs within classes of drugs. The change in drug price score per prescription was - 0.15 (95% Cl, - 0.27 to - 0.04; P = 0.01). A score of 3 was assigned to the most expensive, 2 was assigned to intermediate-priced, and 1 was assigned to the least expensive drug or drugs in the class. An increase of 0.74 months' (Cl, 0.49 to 0.98; P < 0.001) supply of medication was dispensed per prescription, reducing dispensing fees. The program was well accepted by the physicians.
▪ Conclusion: This relatively simple educational intervention can help physicians to reduce their patients' drug expenses and may serve as a model for incorporating cost information into the routine practice of medicine.

Get full access to this article

View all available purchase options and get full access to this article.

Appendix. Articles about Drug Cost or Efficacy

1.
Nightingale S and Morrison J. Generic drugs and the prescribing physician. JAMA. 1987;258:1200-4.
2.
Bloom BWierz D, and Pauly M. Cost and price of comparable branded and generic pharmaceuticals. JAMA. 1986;256:2523-30.
3.
Lasagna L. The economics of generic prescribing: winners and losers [Editorial]. JAMA. 1986;256:2566.
4.
Faich GMorrison JDutra EHare D, and Rheinstein P. Reassurance about generic drugs [Editorial]. N Engl J Med. 1987;316:1473-5.
5.
Strom B. Generic drug substitution revisited. N Engl J Med. 1987;316:1456-62.
6.
. Approved Drug Products with Therapeutic Equivalence Evaluations. 7th ed. Rockville, Maryland: U.S. Department of Health and Human Services; 1987:1-1, 1-8, 3-136, 3-137, 3-204, 3-236, 3-241.
7.
Stoudemire ABrown J, and Harris R. Propranolol and depression: a reevaluation based on a pilot clinical trial. Psychiatr Med. 1984;2:211-8.
8.
. The beta-blocker heart attack trial. JAMA. 1981;246:2073-4.
9.
. A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results. JAMA. 1982;247:1707-14.
10.
Avorn JEveritt D, and Weiss S. Increased antidepressant use in patients prescribed beta-blockers. JAMA. 1986;255:357-60.
11.
Presser PKosola J, and Bowers C. The 24-hour effects of glyburide and chlorpropamide after chronic treatment of type II diabetic patients. Am J Med Sci. 1985;289:179-85.
12.
Skillman T and Feldman J. The pharmacology of sulfonylureas. Am J Med. 1981;70:361-72.
13.
Groop LWahlin-Boll E, and Groop P. Pharmacokinetics and metabolic effects of glibenclamide and glipizide in type 2 diabetics. Eur J Clin Pharmacol. 1985;28:697-704.
14.
Frazier L and Corey G. Acute bacterial sinusitis. N C Med J. 1986;47:115-7.
15.
Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg. Veterans Administration Cooperative Study Group on Antihypertensive Agents. JAMA. 1970;213:1143-52.
16.
Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg. Veterans Administration Cooperative Study Group on Antihypertensive Agents. JAMA. 1967;202:1028-34.
17.
Five-year findings of the Hypertension Detection and Follow-up Program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension. Hypertension Detection and Follow-up Program Cooperative Group. JAMA. 1979;242:2562-71.
18.
The Australian therapeutic trial in mild hypertension. Report by the Management Committee. Lancet. 1980;1:1261-7.
19.
Helgeland A. Treatment of mild hypertension: a five year controlled drug trial. The Oslo Study. Am J Med. 1980;69:725-32.
20.
Smith W. Treatment of mild hypertension: results of a ten-year intervention trial. U.S. Public Health Service Hospitals Cooperative Study Group. Circ Res. 1977;40(5 Suppl 1):I98-105.
21.
Roberts W. Blood lipid levels and antihypertensive therapy. Am J Cardiol. 1987;60:33E-35E.
22.
Holtzman ERosenthal TGoldbourt U, and Segal P. Do beta-blockers alter lipids and what are the consequences? J Cardiovasc Pharmacol. 1987;10(Suppl 2):S86-S92.
23.
Ames R. The influence of non-beta-blocking drugs on the lipid profile: are diruretics outclassed as initial therapy for hypertension? Am Heart J. 1987;114:998-1006.
24.
Kaplan N. Antihypertensive drugs: how different classes can impact patients' coronary heart disease risk profile and quality of life. Am J Med. 1987;82(Suppl 1A):9-14.
25.
Samuel PChin GFenderson RSchoenfeld BGonasun L, and Lieberman S. Improvement of the lipid profile during long-term administration of pindolol and hydrochlorothiazide in patients with hypertension. Am J Cardiol. 1986;57:24C-28C.
26.
Wallin J and Shah S. Beta-adrenergic blocking agents in the treatment of hypertension. Choices based on pharmacologic properties and patient characteristics. Arch Intern Med. 1987;147:654-9.
1.
Waldo D. Outpatient prescription drug spending by the Medicare population. Health Care Financ Rev. 1989;9:83-9.
2.
Craig WUman SShaw WRamgopal VEagan L, and Leopold E. Hospital use of antimicrobial drugs. Survey at 19 hospitals and results of antimicrobial control program. Ann Intern Med. 1978;89:793-5.
3.
Durbin WLapidas B, and Goldmann D. Improved antibiotic usage following introduction of a novel prescription system. JAMA. 1981;246:1796-800.
4.
Britton HSchwinghammer T, and Romano M. Cost containment through restriction of cephalosporins. Am J Hosp Pharm. 1981;38:1897-900.
5.
Woodward RMedoff GSmith M, and Gray J. Antibiotic cost savings from formulary restrictions and physician monitoring in a medical-school-affiliated hospital. Am J Med. 1987;83:817-23.
6.
Clapham CHepler CReinders TLehman M, and Pesko L. Economic consequences of two drug-use control systems in a teaching hospital. Am J Hosp Pharm. 1988;45:2329-40.
7.
Briceland LNightingale CQuintiliani RCooper B, and Smith K. Antibiotic streamlining from combination therapy to monotherapy utilizing an interdisciplinary approach. Arch Intern Med. 1988;148:2019-22.
8.
Avorn J and Soumerai S. Improving drug-therapy decisions through educational outreach. A randomized controlled trial of academically based "detailing." N Engl J Med. 1983;308:1457-63.
9.
Schaffner WRay WFederspiel C, and Miller W. Improving antibiotic prescribing in office practice. A controlled trial of three educational methods. JAMA. 1983;250:1728-32.
10.
Klein LCharache P, and Johannes R. Effect of physician tutorials on prescribing patterns of graduate physicians. J Med Educ. 1981;56:504-11.
11.
Cardinale V, ed. Drug Topics Red Book, 1988: Annual Pharmacists' Reference. Oradell, New Jersey: Medical Economics Co.; 1988.
12.
Snedecor G and Cochran W, eds. Statistical Methods. 6th ed. Ames, Iowa: Iowa State University Press; 1967:327-9.
13.
Bloom BWierz D, and Pauly M. Cost and price of branded and generic pharmaceuticals. JAMA. 1986;256:2523-30.
14.
Kreling D. Assessing potential prescription reimbursement changes: estimated acquisition costs in Wisconsin. Health Care Finance Rev. 1989;10:67-75.
15.
Marton KTul V, and Sox H. Modifying test-ordering behavior in the outpatient medical clinic. A controlled trial of two educational interventions. Arch Intern Med. 1985;145:816-21.
16.
Gehlbach SWilkinson W, and Hammond W. Improving drug prescribing in a primary care practice. Med Care. 1984;22:193-201.

Information & Authors

Information

Published In

cover image Annals of Internal Medicine
Annals of Internal Medicine
Volume 115Number 215 July 1991
Pages: 116 - 121

History

Published in issue: 15 July 1991
Published online: 1 December 2008

Keywords

Authors

Affiliations

J. Trig Brown, MD, MPH
George W. Divine, PhD
Gayle R. Fleming, RPh
William C. Siegal, MD, MPH
Moise A. Khayrallah, MA
From Duke University Medical Center, Durham, North Carolina; and the School of Education, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. For current author addresses, see end of text.

Metrics & Citations

Metrics

Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. For an editable text file, please select Medlars format which will download as a .txt file. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format





Download article citation data for:
Linda M. Frazier, J. Trig Brown, George W. Divine, et al. Can Physician Education Lower the Cost of Prescription Drugs?: A Prospective, Controlled Trial. Ann Intern Med.1991;115:116-121. doi:10.7326/0003-4819-115-2-116

View More

Get Access

Login Options:
Purchase

You will be redirected to acponline.org to sign-in to Annals to complete your purchase.

Create your Free Account

You will be redirected to acponline.org to create an account that will provide access to Annals.

View options

PDF/ePub

View PDF/ePub

Related in ACP Journals

Media

Figures

Other

Tables

Share

Share

Copy the content Link

Share on social media